Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-25

FDA Approved: ETHOSUXIMIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Ethosuximide submitted by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

SUPPL AP for ETHOSUXIMIDE (ETHOSUXIMIDE)